首页> 美国卫生研究院文献>American Journal of Human Genetics >Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p and evidence for genetic heterogeneity.
【2h】

Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p and evidence for genetic heterogeneity.

机译:1p号染色体上皮肤恶性黑色素瘤-增生性痣(CMM / DN)的基因座的进一步证据以及遗传异质性的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Assignment of a susceptibility locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) to chromosome 1p remains controversial. We examined the relationship between CMM/DN and markers D1S47, PND, and D1S160 on seven new families (set B) plus updated versions of six previously reported families (set A). Three linkage analyses were performed: (1) CMM alone--all individuals without confirmed melanoma or borderline lesions were considered unaffected (model I); (2) CMM/DN with variable age at onset and sporadics (model II); and (3) CMM/DN using the model of Bale et al. (model III). For CMM alone and D1S47, Zmax = 3.12 at theta = .10. For D1S160 and CMM alone, Zmax = 1.76 at theta = .10. PND showed no evidence for linkage to CMM alone. Models II and III showed strong evidence for linkage to D1S47, D1S160, and PND in the set A pedigrees but not in the set B families. We tested for homogeneity of CMM/DN (model II) by splitting families into two groups on the basis of (1) the proportion of CMM/DN cases and (2) the occurrence of immune-related tumors. In group 1 there was significant evidence of heterogeneity with both D1S47 and D1S160, and in group 2 there was significant evidence of heterogeneity with D1S160. Thus, diagnostic, clinical, and genetic heterogeneity are the likely reasons that previous studies have failed to confirm linkage of CMM/DN to chromosome 1p. The results showed significant evidence for a CMM locus linked to D1S47, as well as significant evidence for heterogeneity with only a subset of the families appearing linked to chromosome 1p.
机译:皮肤恶性黑色素瘤-增生性痣(CMM / DN)的敏感性位点分配给染色体1p仍存在争议。我们在七个新家族(B组)以及六个先前报道的家族(A组)的更新版本中检查了CMM / DN与标记D1S47,PND和D1S160之间的关系。进行了三个连锁分析:(1)单独的CMM-所有未确诊黑色素瘤或边缘性病变的个体均视为未受影响(模型I); (2)发病年龄可变且散发的CMM / DN(模型II); (3)使用Bale等人的模型的CMM / DN。 (模型III)。仅对于CMM和D1S47,在θ= 0.10时Zmax = 3.12。仅对于D1S160和CMM,在θ= .10时Zmax = 1.76。 PND没有证据表明单独与CMM相关。模型II和III显示出有力的证据证明在A组血统中与D1S47,D1S160和PND有关联,而在B组中则没有。我们根据(1)CMM / DN病例的比例和(2)免疫相关肿瘤的发生情况,通过将家族分为两组来测试CMM / DN(模型II)的同质性。在第1组中,有明显的证据表明D1S47和D1S160均具有异质性,在第2组中,有明显的证据表明D1S160和D1S160具有异质性。因此,诊断,临床和遗传异质性是先前研究未能证实CMM / DN与1p染色体连锁的可能原因。结果显示了与D1S47相关的CMM基因座的重要证据,以及异质性的重要证据,只有一部分家庭出现与1p染色体相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号